Cel-Sci Corporation (CVM) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
8229 BOONE BLVD . VIENNA, VA 22182 |
| State of Incorp. | CO |
| Fiscal Year End | September 30 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2022 Q4 | 6/30/2022 Q3 | 3/31/2022 Q2 | 12/31/2021 Q1 | 9/30/2021 Q4 | 6/30/2021 Q3 | 3/31/2021 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 22,672 | 28,074 | 34,283 | 37,110 | 42,212 | 47,110 | 17,583 | ||
| Cash and cash equivalents | 22,672 | 28,074 | 34,283 | 37,110 | 36,060 | 35,958 | 6,431 | ||
| Short-term investments | 6,151 | 11,152 | 11,151 | ||||||
| Receivables | 55 | 55 | 55 | 55 | |||||
| Inventory, net of allowances, customer advances and progress billings | 2,002 | 2,007 | 1,579 | 1,459 | |||||
| Inventory | 2,002 | 2,007 | 1,579 | 1,459 | |||||
| Prepaid expense | 762 | 709 | 987 | 724 | 998 | 979 | 722 | ||
| Deposits current assets | 9 | 48 | |||||||
| Other undisclosed current assets | 2,173 | 2,005 | 3,979 | ||||||
| Total current assets: | 25,436 | 30,955 | 37,275 | 41,867 | 45,272 | 49,731 | 19,867 | ||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 164 | ||||||||
| Finance lease, right-of-use asset | 10,938 | 11,389 | 11,808 | 12,253 | 12,692 | 13,125 | 12,815 | ||
| Operating lease, right-of-use asset | 1,884 | 1,929 | 1,972 | 2,014 | 2,056 | 1,047 | 1,121 | ||
| Property, plant and equipment | 11,889 | 12,394 | 12,871 | 13,290 | 13,664 | 13,548 | 12,599 | ||
| Intangible assets, net (including goodwill) | 212 | 222 | 235 | 276 | 279 | 292 | |||
| Intangible assets, net (excluding goodwill) | 212 | 222 | 235 | 276 | 279 | 292 | |||
| Other undisclosed noncurrent assets | 0 | 248 | 1,911 | (26,099) | (25,127) | ||||
| Total noncurrent assets: | 25,088 | 25,934 | 26,886 | 27,804 | 30,598 | 1,900 | 1,700 | ||
| Other undisclosed assets | 28,010 | 26,798 | |||||||
| TOTAL ASSETS: | 50,524 | 56,890 | 64,161 | 69,672 | 75,870 | 79,642 | 48,365 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 2,461 | 1,846 | 2,375 | 2,093 | 2,535 | 3,013 | 2,910 | ||
| Accounts payable | 1,618 | 853 | 1,317 | 1,193 | 1,676 | 2,144 | 2,391 | ||
| Accrued liabilities | 842 | 993 | 1,058 | 900 | 859 | 868 | 519 | ||
| Derivative instruments and hedges, liabilities | 2 | 437 | 919 | 2,283 | |||||
| Due to related parties | 471 | 496 | 488 | 475 | 266 | 533 | 457 | ||
| Other undisclosed current liabilities | 1,731 | 1,674 | 1,611 | 764 | 699 | 692 | 172 | ||
| Total current liabilities: | 4,664 | 4,015 | 4,474 | 3,333 | 3,937 | 5,157 | 5,823 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 13,572 | 14,021 | 14,434 | 14,862 | 15,274 | 14,566 | 13,086 | ||
| Finance lease, liability | 11,721 | 12,125 | 12,494 | 12,880 | 13,252 | 13,603 | 12,055 | ||
| Operating lease, liability | 1,850 | 1,896 | 1,940 | 1,981 | 2,021 | 963 | 1,031 | ||
| Liabilities, other than long-term debt | 125 | 125 | 125 | 125 | 125 | 125 | 125 | ||
| Other liabilities | 125 | 125 | 125 | 125 | 125 | 125 | 125 | ||
| Total noncurrent liabilities: | 13,697 | 14,146 | 14,559 | 14,987 | 15,399 | 14,691 | 13,211 | ||
| Total liabilities: | 18,360 | 18,161 | 19,033 | 18,320 | 19,336 | 19,848 | 19,033 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 32,163 | 38,728 | 45,128 | 51,351 | 56,534 | 59,794 | 29,332 | ||
| Common stock | 434 | 434 | 433 | 433 | 432 | 430 | 408 | ||
| Additional paid in capital | 486,626 | 484,730 | 481,497 | 477,898 | 474,299 | 469,356 | 429,977 | ||
| Accumulated deficit | (454,897) | (446,435) | (436,803) | (426,979) | (418,196) | (409,992) | (401,053) | ||
| Total stockholders' equity: | 32,163 | 38,728 | 45,128 | 51,351 | 56,534 | 59,794 | 29,332 | ||
| TOTAL LIABILITIES AND EQUITY: | 50,524 | 56,890 | 64,161 | 69,672 | 75,870 | 79,642 | 48,365 | ||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 9/30/2022 Q4 | 6/30/2022 Q3 | 3/31/2022 Q2 | 12/31/2021 Q1 | 9/30/2021 Q4 | 6/30/2021 Q3 | 3/31/2021 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Operating expenses | (8,948) | (8,719) | (9,552) | (8,843) | (8,474) | (10,457) | (8,533) | |
| Other undisclosed operating income | 365 | |||||||
| Operating loss: | (8,948) | (8,719) | (9,552) | (8,843) | (8,474) | (10,457) | (8,533) | |
| Nonoperating income | 108 | 333 | 241 | 761 | 554 | |||
| Investment income, nonoperating | 333 | 761 | 554 | |||||
| Loss from continuing operations before equity method investments, income taxes: | (8,840) | (8,719) | (9,552) | (8,510) | (8,233) | (9,695) | (7,979) | |
| Other undisclosed loss from continuing operations before income taxes | (3,302) | |||||||
| Loss before gain (loss) on sale of properties: | (8,840) | (8,719) | (9,552) | (8,510) | (8,233) | (9,695) | (11,281) | |
| Other undisclosed net income (loss) | 73,779 | (272) | ||||||
| Net income (loss): | 64,939 | (8,719) | (9,552) | (8,783) | (8,233) | (9,695) | (11,281) | |
| Other undisclosed net income (loss) attributable to parent | (73,401) | (913) | (272) | 28 | 757 | |||
| Net loss attributable to parent: | (8,462) | (9,633) | (9,823) | (8,783) | (8,205) | (8,938) | (11,281) | |
| Other undisclosed net loss available to common stockholders, basic | (635) | (294) | (265) | |||||
| Net loss available to common stockholders, basic: | (9,097) | (9,927) | (9,823) | (8,783) | (8,205) | (9,203) | (11,281) | |
| Other undisclosed net income (loss) available to common stockholders, diluted | (25) | 151 | (1,234) | |||||
| Net loss available to common stockholders, diluted: | (9,097) | (9,927) | (9,823) | (8,808) | (8,054) | (10,437) | (11,281) | |
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2022 Q4 | 6/30/2022 Q3 | 3/31/2022 Q2 | 12/31/2021 Q1 | 9/30/2021 Q4 | 6/30/2021 Q3 | 3/31/2021 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 64,939 | (8,719) | (9,552) | (8,783) | (8,233) | (9,695) | (11,281) | |
| Comprehensive income (loss), net of tax, attributable to parent: | 64,939 | (8,719) | (9,552) | (8,783) | (8,233) | (9,695) | (11,281) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.